"GLP-1 medications can significantly change how people experience hunger and satiety. For many, the reduction in constant food-related thoughts feels like a relief-sometimes the first quiet moment in years. This physiological shift can make behavior change feel newly possible. But medication does not provide structure. It does not decide when people move, how they manage stress, or which behaviors become routine. From a psychological perspective, GLP-1s create opportunity, not organization."
"Behavioral science consistently shows that people repeat behaviors that feel easy to initiate. When an action requires planning, preparation, or sustained self-control, adherence declines-even when motivation is high. Many health behaviors fail not because people lack discipline, but because the environments in which they are attempted create friction. Settings that demand performance, tracking, or comparison increase the perceived cost of action. In contrast, environments that lower barriers-through simplicity, accessibility, or familiarity-support repetition."
GLP-1 medications reduce persistent hunger and food-related thoughts, creating physiological opportunity for behavior change without providing structure. Medication alters appetite signals but does not determine movement, stress management, or routine formation. Habit repetition is driven by ease of initiation; actions that require planning or sustained self-control show lower adherence. Many health behaviors fail because environmental friction raises the perceived cost of action, while simplicity, accessibility, and familiarity support repetition. Modern cognitive demands produce fatigue that impairs self-regulation, and exposure to natural settings can restore attention and reduce mental load, making sustained behavior change more likely.
Read at Psychology Today
Unable to calculate read time
Collection
[
|
...
]